Glucotrack (GCTK) Research & Development (2016 - 2020)
Historic Research & Development for Glucotrack (GCTK) over the last 7 years, with Q4 2020 value amounting to $264000.0.
- Glucotrack's Research & Development fell 3439.1% to $264000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $1.5 million, marking a year-over-year decrease of 460.77%. This contributed to the annual value of $4.7 million for FY2023, which is N/A changed from last year.
- Per Glucotrack's latest filing, its Research & Development stood at $264000.0 for Q4 2020, which was down 3439.1% from $476000.0 recorded in Q3 2020.
- Glucotrack's Research & Development's 5-year high stood at $1.4 million during Q4 2017, with a 5-year trough of $264000.0 in Q4 2020.
- Moreover, its 5-year median value for Research & Development was $580517.0 (2016), whereas its average is $609477.6.
- Its Research & Development has fluctuated over the past 5 years, first soared by 10971.89% in 2017, then crashed by 6687.53% in 2019.
- Glucotrack's Research & Development (Quarter) stood at $654984.0 in 2016, then soared by 109.72% to $1.4 million in 2017, then decreased by 11.57% to $1.2 million in 2018, then plummeted by 66.88% to $402384.0 in 2019, then plummeted by 34.39% to $264000.0 in 2020.
- Its last three reported values are $264000.0 in Q4 2020, $476000.0 for Q3 2020, and $379000.0 during Q2 2020.